This section of the website is intended for medical professionals only. To access the client page and online store, please click below.
News
Articles
GHC Genetics to use innovative approach in sequencing oral and intestinal microbiome
Nanopore sequencing belongs to the so-called "third generation" of sequencing, which allows direct reading of single-stranded DNA or RNA without the need for prior amplification (e.g., using PCR) or chemical labeling. The use of nanopores for sequencing was first described in the late 1980s by several American scientists. David Deamer, George Church, and Hagan Bayley independently described the sequencing of a single DNA molecule using electrophoresis and membrane nanopores. This method does not use a fluorescent signal, but measures the voltage changes that occur when DNA passes through an electrically charged pore in the membrane.
Mandatory notification – flexible scope of accreditation
Dear customers, in accordance with our legal obligation, we hereby inform you about the application of flexible accreditation scope.
Check out the latest issue of our GHC magazine
The latest issue of our GHC magazine (2/2025) has just been published.
GHC Genetics significantly supported the "Plešouni" project for children with cancer
The Plešouni project is a Czech charity educational multimedia project - an animated series (13 episodes) is being created, which explains to children in an understandable and sensitive way what to expect during treatment, how chemotherapy works or how to cope with psychologically challenging moments. The series is created with an emphasis on humour, empathy and playfulness, which helps children process complex emotions and information. In addition to the series, the project also includes a mobile and tablet app that serves as an interactive guide to treatment. GHC Genetics financially supported this project and adopted an important character within the bald identity - Captain CHEMO. He is the main sidekick to children going through challenging cancer treatments in their upcoming series.